20277 results for «»
20277 results
Pablo Juan-Salvadores
Vigo, Spain
Michael Lauterbach
Luxembourg, Luxembourg
Kevin Millar
Dublin, Ireland
Advancing percutaneous treatment of pulmonary embolism with computer-assisted vacuum thrombectomy
14 May 2024 – From EuroPCR 2024
Join this session to delve into innovations in computer-assisted vacuum thrombectomy for acute pulmonary embolism, leveraging real-life case scenarios to share practical experiences and discuss treatment strategies. Amidst the current surge in scientific research, ongoing trials like STORM PE and STRIKE PE are pivotal in shaping...
Ultra-low contrast techniques to improve the safety and quality of PCI in complex and high-risk patients
14 May 2024 – From EuroPCR 2024
Tune in to this session to discover how reducing reliance on contrast opacification enhances procedural safety and enables more thorough revascularization in complex PCI scenarios. Learn that ultra-low contrast (ULC) PCI encompasses various interventional skills and specialized tools, many already familiar to interventional cardiologists. Embrace a...
Revisiting thrombus aspiration in STEMI with continuous power aspiration system
15 May 2024 – From EuroPCR 2024
Tune into this 2024 session for insights into the latest ESC guidelines, strategies to prevent and treat no reflow, and an examination of trials like TASTE, TAPAS, and TOTAL on coronary thrombus management. Explore also the outcomes of the CHEETAH study, pondering a potential paradigm shift,...
Victor Tadros
Nimes, France
Jean Guillaume Dillinger
Paris, France
Andrea Milzi
Lugano, Switzerland
Sirolimus-coated balloon: exploring the case- and clinical-based evidences
16 May 2024 – From EuroPCR 2024
Browse this EuroPCR 2024 session to explore the safety and efficacy of sirolimus-coated balloons from pre-clinical data, review MagicTouch data from real-world populations with case-based examples, and learn about the MagicTouch sirolimus-coated balloon clinical programs. Discover insights and takeaways from the significance of the EASTBOURNE subgroups,...
Three tailored devices to ease the complex PCI procedures
14 May 2024 – From EuroPCR 2024
At EuroPCR 2024, a round table featuring Jianfang Luo, Benjamin Faurie, and Sevket Gorgulu addresses the challenge of streamlining complex PCI procedures. The discussion focuses on three innovative devices: Expressman™, a guiding extension catheter renowned for its one-piece design and side holes, ensuring adequate antegrade blood...
PCI in patients with diabetes: next generation DES + DCB stent platform in action
14 May 2024 – From EuroPCR 2024
Watch this session on PCI in diabetic patients to learn about a groundbreaking technology addressing the complexities of this critical subgroup. Discover the next-generation DES and DCB stent platform and the innovative Envisolution technology behind it. Understand how it works, its advantages in managing complex cases,...
ShortCut leads the way for leaflet modification
14 May 2024 – From EuroPCR 2024
Check out this interview with Philippe Genereux, Danny Dvir and Susheel Kodali, where they discuss the ShortCut trial. Learn about the ShortCut device, the first tool for splitting leaflets in valve-in-valve procedures. Hear key insights, including the dual splitting technique, comparisons between BASILICA and ShortCut, and...
Mechanical circulatory support in cardiogenic shock: where are we now?
14 May 2024 – From EuroPCR 2024
In this EuroPCR 2024 interview, Alaide Chieffo and Gabor Toth discuss mechanical circulatory support in cardiogenic shock and myocardial infarction. They address the ECLS-SHOCK trial's lack of benefit from prophylactic ECMO, stressing improved patient selection and timing. They contrast this with the DanGer Shock study, where...
How the latest recommendations on MINOCA can impact our practice
14 May 2024 – From EuroPCR 2024
Join Vijay Kunadian and Salvatore Brugaletta as they talk about the latest ESC guidelines for MINOCA (Myocardial Infarction with Non-Obstructive Coronary Arteries). Together, they review the crucial aspects of identifying MINOCA patients, how to diagnose them effectively using available diagnostic tools and the importance of post-treatment...
Bioadaptor RCT 2 years: could we further improve long-term CAD outcomes vs DES?
14 May 2024 – From EuroPCR 2024
Follow this exchange between Antonio Colombo, Stefan Verheye, and Davide Capodanno as they discuss the past, present, and future of drug-eluting stents. They address the current limitations, emphasizing the issue of vessel caging, and suggest improvements, particularly highlighting the new Bioadaptor with uncaging bioresorbable elements that...
Mental health in the cathlab: is everything really ok?
14 May 2024 – From EuroPCR 2024
Watch Alison Dahlmann and Kristin Rykkje-Johannessen discuss the impact of working in a cathlab on mental health. Despite limited clinical evidence, a two-month online survey revealed that 93% of cathlab workers, across all healthcare professional categories, find the environment stressful, with over 92% experiencing stress and...
Antiplatelet de-escalation after complex PCI: when and how?
14 May 2024 – From EuroPCR 2024
It is now understood that ischemia is not the only risk to consider, as bleeding also plays a significant role. This is why de-escalation is now recommended for patients with complex PCI, as all de-escalation strategies reduce bleeding risk. Discover more about the three different de-escalation...
Asymptomatic severe aortic stenosis, how will new evidence change our practice?
15 May 2024 – From EuroPCR 2024
Victoria Delgado and Martin Leon discuss how to treat patients with asymptomatic severe aortic stenosis at an earlier stage and how current trials may change our practice in the future and broaden the indications.
This interview was filmed at EuroPCR 2024: see more videos here.
NOTION-2: first TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis
15 May 2024 – From EuroPCR 2024
Christopher Cook interviews Ole de Backer about this study he presented at EuroPCR 2024: It provides further data concerning the 1-year outcome of younger AS patients with tricuspid valve anatomy treated with TAVI compared to SAVR. TAVI and SAVR showed similar rates of the primary endpoint...
